A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN: EASY AM).
Phase of Trial: Phase III
Latest Information Update: 09 Mar 2017
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms BEGIN; BEGIN-EASY-AM
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 29 Nov 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 29 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.